Approvals/TGA/OCTREOTIDE DEPOT octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack

Approved

STANDARD

OCTREOTIDE DEPOT octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack

Teva Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ad5a8c8bc80e8bf3
Product Name: OCTREOTIDE DEPOT octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack
Artg Id: 321282
Artg Name: OCTREOTIDE DEPOT octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack
Sponsor: Teva Pharma Australia Pty Ltd
Company Detail Path: /organization/teva-pharma-australia-pty-ltd
Artg Date: 2020-11-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01753-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02604-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ad5a8c8bc80e8bf3

Type

Standard